observed that NLRP3-deficient aggravates NASH, which makes serum alanine transaminase(ALT), aspartate transaminase (AST), and NAFLD activity inflammation scores increase (60). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.